Salix Pharmaceuticals, Ltd.

397 articles about Salix Pharmaceuticals, Ltd.

• Salix Pharmaceuticals, Ltd. To Present At Two Investment Conferences During May

  5/8/2006

• Salix Pharmaceuticals, Ltd. Reports 1Q2006 Results

  5/4/2006

• Salix Pharmaceuticals, Ltd. Announces 1Q2006 Financial Results Conference Call And Webcast

  4/20/2006

• Salix Pharmaceuticals, Ltd. Announces Completion Of OsmoPrep(TM) Versus Liquid Bowel Cleanser Comparison Study

  4/19/2006

• The Day In Review: Genentech, Inc. Outperforms In Q1

  4/11/2006

• Salix Pharmaceuticals, Ltd.'s MoviPrep(R) Issued Approvable Letter By FDA

  4/11/2006

• Salix Pharmaceuticals, Ltd. OsmoPrep(TM) Tablets Granted FDA Marketing Approval

  3/17/2006

• Salix Pharmaceuticals, Ltd. Reports 4Q2005 And FY2005 Results

  2/24/2006

• Salix Pharmaceuticals, Ltd. Announces 4Q2005 And FY2005 Financial Results Conference Call And Webcast

  1/31/2006

• Salix Pharmaceuticals, Ltd. Development Update; XIFAXAN(R) Trials Initiated In C. difficile-Associated Diarrhea, Irritable Bowel Syndrome And Hepatic Encephalopathy

  1/11/2006

• Salix Pharmaceuticals, Ltd. Announces Acceleration Of Stock Option Vesting

  1/5/2006

• Salix Pharmaceuticals, Ltd. Announces Completion Of First XIFAXAN(R) Travelers' Diarrhea Prevention Study

  1/4/2006

• Salix Pharmaceuticals, Ltd. Agrees To Pay $37 Million For Product Rights

  12/7/2005

• Salix Pharmaceuticals, Ltd. Reports American College Of Gastroenterology COLAZAL(R) Update; COLAZAL(R)-Related Data Presented In Two Poster Presentations

  11/1/2005

• Salix Pharmaceuticals, Ltd. Reports American College Of Gastroenterology XIFAXAN(R) Update; XIFAXAN(R) Studied In Six Investigator-Initiated Trials

  10/31/2005

• Salix Pharmaceuticals, Ltd. Announces 3Q2005 Financial Results Conference Call And Webcast

  10/25/2005

• The Day In Review: Biotech Rises Again

  5/18/2005